The lpr locus was defined by an autosomai recessive mutation initially observed in strain MRL (1). Whereas nonmutant mice of this strain develop late-onset autoimmune disease characterized by chronic glomerulonephritis, MRL-lpr/lpr mice experience severe ear!y-onset subacute glomerulonephritis, arteritis, and arthritis associated with massive lymphadenopathy and splenomegaly (1-3). The lymph nodes and spleens of lpr homozygotes are expanded by an abnormal population of cells that coexpress cell surface determinants usually restricted to T cells (Thy-1, Ly-1) or B cells [Ly-5(B220)] (4-9), and are deficient in their ability to produce interleukin 2 (IL-2) 1 (9-12). These aberrant cells were clearly shown not to be B cells, in that they had no rearrangements of Ig heavy chain genes (6). MRL-lpr/+ resemble MRL-+/+ mice in terms of disease patterns, longevity, and phenotypic and functional characteristics of their lymphocytes, indicating that the mutation is fully recessive in this strain.To determine if this mutation would produce similar abnormalities when present on other genetic backgrounds, lpr was backcrossed onto strains NZB/BINJ, SJL/J, C3H/HeJ, AKR/J, C57BL/6J, and BALB/cJ. Ongoing phenotypic, functional, and histopathologic studies of mice (from these strains) homozygous for lpr have shown that, although aberrant T cells were detected in the lymphoid tissues of mice from all strains (6, 9, and H. C. Morse III, W. F. Davidson, and J. B. Roths, unpublished observations), lpr/lpr mice differed considerably among strains in the degree of lymphadenopathy they exhibited, as well as in their longevity and rates of development, and severity of the autoimmune disease they incurred (5, 9-13, and J. B. Roths and E. D. Murphy, unpublished observations).During the course of these studies, it was noted that the survival of SJL-lpr/+ mice was shortened in comparison to SJL-+/+ mice, suggesting that, in this strain, lpr had an effect in the heterozygous state. To evaluate this possibility,